Development and Validation an LC Method for the Determination of Bendroflumethiazide in Human Plasma and its Pharmacokinetics

A simple, rapid, sensitive high performance liquid chromatography method with fluorescent detection was developed and validated for the determination of bendroflumethiazide in human plasma. Extraction from the plasma was by liquid-liquid extraction using ethyl acetate. Mosapride citrate was used as the internal standard. The chromatographic separation was performed on reverse phase LiChrosphere C18 column with mobile phase comprising of acetonitrile and phosphate buffer (38:62 v/v). The assay precision ranged from 0.9–12.5 and accuracy between 96.8–108.8%, revealing that the method has good reproducibility over the concentration range of 0.98–100.16 ng mL⁻¹. The validated method has been applied to analyze the bendroflumethiazide concentrations for application in pharmacokinetic, bioavailability or bioequivalence studies.     

Development and Validation of an HPLC Method for Determination of Ceftiofur Sodium

An isocratic high-performance liquid chromatographic method has been developed for assay of ceftiofur sodium in drug substance and in sterile powder for injection. Chromatography was performed on a 250 mm × 4.6 mm, 5 μm particle, C₁₈ column with a 78:22 (v/v) mixture of 0.02 m disodium hydrogen phosphate buffer (pH adjusted to 6.0 with 85% orthophosphoric acid) and acetonitrile as mobile phase, at a flow rate of 1.0 mL min⁻¹. The separation was monitored by UV detection at 292 nm. Validation of the method for linearity and range, intra- and inter-day precision, accuracy, specificity, recovery, robustness, and limits of quantification and detection yielded good results. The calibration plot was linear from 20.0–120.0 μg mL⁻¹ and the correlation coefficient was 0.9999. It was shown that ceftiofur was degraded under acidic, alkaline, oxidative, and photolytic conditions. The method was found to be stability-indicating and could be used for routine analysis of ceftiofur sodium for injection.     

A Stability-Indicating LC Method for the Simultaneous Determination of Telmisartan and Ramipril in Dosage Form

A simple, rapid, and precise method is developed for the quantitative simultaneous estimation of telmisartan and ramipril in combined pharmaceutical dosage form. A chromatographic separation of the two drugs was achieved with an ACE 5 C₁₈, 25-cm analytical column using buffer–acetonitrile (55:45 v/v). The buffer used in mobile phase contains 0.1 M sodium perchlorate monohydrate in double distilled water pH adjusted 3.0 with trifluoroacetic acid. The instrumental settings are flow rate of 1.5 mL min⁻¹, column temperature at 30 °C, and detector wavelength of 215 nm using a photodiode array detector. The resolution between ramipril and telmisartan were found to be more than 5. Theoretical plates for ramipril and telmisartan were 13,022 and 6,629. Tailing factor for ramipril and telmisartan was 0.94 and 0.98. Telmisartan, ramipril and their combination drug product were exposed to thermal, photolytic, hydrolytic and oxidative stress conditions, and the stressed samples were analysed by the proposed method. Peak homogeneity data of telmisartan and ramipril is obtained using photodiode array detector, in the stressed sample chromatograms, demonstrated the specificity of the method for their estimation in presence of degradants. The described method shows excellent linearity over a range of 20–400 μg mL⁻¹ for telmisartan and 2.5–50 μg mL⁻¹ for ramipril. The correlation coefficient for telmisartan and ramipril are 1. The relative standard deviation for six measurements in two sets of each drug in tablets was always less than 2%. The proposed method was found to be suitable and accurate for quantitative determination and the stability study of telmisartan and ramipril in pharmaceutical preparations.     

Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs

A simple high performance liquid chromatographic method for the determination of process-related impurities in bulk drug of the central anticholinergic compound pridinol mesylate, has been developed and validated. Spectroscopically characterized synthetic impurities were used as standards. The chromatographic separation was optimized employing an experimental design strategy, and was achieved on a C₁₈ column with a mobile phase containing 50 mM potassium phosphate buffer (pH 6.4), MeOH and 2-propanol (20:69:11, v/v/v), delivered at a flow rate of 1.0 mL min⁻¹. UV detection was performed at 245 nm. The optimized method was thoroughly validated, demonstrating to be selective, when the chromatogram was recorded with a diode-array detector and peak purities were evaluated (>0.9995). The method is robust and linear (r² > 0.99) over the range 0.05-2.5% (5-250% with regards to the 1% specification limit for both process-related impurities); it is also precise, regarding repeatability (RSD ≤ 1.5% for all of the analytes) and intermediate precision aspects and LOQ values for the impurities are below 0.01%. Method accuracy, evidenced by low bias of the results and analyte recoveries in the range of 99.1-102.7%, was assessed at five analyte concentration levels. The usefulness of the determination was also demonstrated through the analysis of different lots of pridinol mesylate bulk substance. The results indicate that the method is suitable for the quality control of the bulk manufacturing of pridinol mesylate drug substance.     

Modified polystyrene,stationary phases for the separation of different aromatic hydrocarbon types by HPLC

Summary One possible method of characterizing chemicall-modified stationary phases is to describe their chromatographic properties. In this study we investigated several chemically-modifiedpolystyrene-divinylbenzene packings for the separation of nitroarenes, polycyclic aromatic hydrocarbons and aminosubstituted aromatic hydrocarbons. Chromatography was carried out on commercially available polymer stationary phases, for example C-18 or vinylpyridine modified polystyrene. In addition, a chemically-immobilized polymer packing was prepared by introducing nitrogroups, which were established by elemental analysis and infrared spectroscopy.     

Optimisation and validation of a generic method for the LC assay of six corticosteroids and salicylic acid in dermopharmaceutical forms

Summary A generic method was developed for the liquid chromatographic (LC) assay of six corticosteraids and salicylic acid in different dermatological formulations containing methylparaben and propylparaben or sorbic acid as preservatives. An adequate separation was obtained using octadecylsilica as stationary phase and a mixture of acetonitrile (MeCN) and 25 mM phosphate buffer of pH 3.5 as mobile phase. Segmented gradient elution was applied from 30 to 45% of MeCN in 9.9 minutes, then from 45 to 96% in 19.0 minutes. UV detection was performed at 240 nm. The method was validated. Very good results were obtained with respect to linearity, selectivity, precision and accuracy.     

Development and Validation of an HPLC Method for the Determination of Dexamethasone, Dexamethasone Sodium Phosphate and Chloramphenicol in Presence of Each Other in Pharmaceutical Preparations

An HPLC method for the determination of dexamethasone, dexamethasone sodium phosphate and chloramphenicol in presence of each other in pharmaceutical preparations has been developed using a Shim-Pack CLC-ODS column (6.0 × 150 mm²). These analytes were separated under isocratic conditions. Various chromatographic parameters including linearity, precision and accuracy have been evaluated. The method was found to be suitable for analysis of these drug substances in presence of each other. The run time was less than 15 min. This method is suitable for application to various dosage forms.     

HPLC coupled with fluorescence detection for the determination of procyanidins in white wines

Summary In this study a high-performance liquid chromatography method was developed for the determination of procyanidin dimers B1, B2, B3, B4 and procyanidin trimers C1 and T2 in white wine using fluorescence detection. This method allowed analysis of white wine with no prior treatment. Limits of quantification were form 12 μg.L⁻¹ to 16 μg.L⁻¹. Reproductibility data for replicate analysis was measured and the CV was less than 4.5%. This method was used for the determination of these compounds in six French white wines.     

Experimental and statistical validation of HPLC analysis of hydroquinone and its 4-methoxyphenol, 4-ethoxyphenol and 4-benzyloxyphenol ethers in cosmetic products

Summary The isocratic HPLC analysis of hydroquinone and its derived ethers in cosmetic preparations, as described in the sixth Directive 95/32/EC of the European Commission, was investigated with a view to determining the fundamental validation parameters of the technique. The calibration lines are highly linear with coefficients of determination >0.9996; the slopes of the calibration equations as well as the slopes normalised to the standard deviations indicate increased sensitivities for all compounds. The method is very reproducible; both the repeatability and the intermediate precision confirm a system performance of <2% variation; the limits of repeatability and intermediate precision are consistently <6% for every compound studied. The detection limits correspond to concentrations of 0.03 and 0.02% (m:m) for hydroquinone and the derived ethers, respectively. Application of the response factor calculation gives reliable results and signifies a practical and economic advantage when compared to laborious calibration with several replicate standard injections. Comparison of the response factor and calibration techniques did not reveal significant differences. The obviously insufficiently efficient extraction preceding chromatographic analysis might constitute the only drawback of the method, especially when the concentrations applied border the allowable.     

Group separation of PCDDs,PCDFs, PACs and aliphatic compounds on an amino bonded stationary phase for HPLC

Summary A HPLC method for the clean up of PCDD and PCDF samples is presented. The method utilizes the possibility of separating compounds according to the number of double bonds by using an amino bonded stationary phase. Aliphatics as well as compounds with higher aromaticity than PCDD/PCDF are removed. In addition, the latter can be collected as one fraction. The fractionation in fast, done in one step and automated.     

Use of neural networks and diode-array detection to develop an isocratic HPLC method for the analysis of nitrophenol pesticides and related compounds

Summary We have used an artificial neural network to optimize the composition of the mobile phase for an isocratic HPLC method for the analysis of nitrophenol pesticides and related compounds, on the basic of different response functions, and have compared the results with those obtained by application of response-surface methodology. These studies resulted in the selection the mobile phase 10:30:15:45 methanol-acetonitrile-tetrahydrofuran-buffer solution (0.1m acetic acid and 0.1m sodium perchlorate); the flow-rate was 1 mL min⁻¹. Under these conditions a chromatogram showing twelve well-resolved peaks was obtained in 14 min. Although the peaks corresponding to ethylparathion and medinoterb acetate overlapped severely, it was possible, by use, of a diode-array spectrophotometer for detection, and by combining the absorbance measured at different wavelengths as the signal, to separate the peaks corresponding to one or other of the compounds. Calibration plots were constructed for the concentration range 2–10 ppm. Detection limits, calculated by the method of Clayton et al., were approximately 0.32–0.69 ppm. The method has been applied to the analysis of these compounds in fortified river water samples, after previous preliminary preconcentration by solid-liquid extraction on a C₁₈ cartridge.     

A Validated Chiral LC Method for the Enantiomeric Separation of Repaglinide on Amylose Based Stationary Phase

A simple, isocratic, normal phase chiral HPLC method was developed and validated for the enantiomeric separation of repaglinide, (S)-(+)-2-ethoxy-4-N [1-(2-piperidinophenyl)-3-methyl-1-butyl] aminocarbonylmethyl] benzoic acid, an antidiabetic in bulk drug substance. The enantiomers of repaglinide were resolved on a ChiralPak AD-H (amylose based stationary phase) column using a mobile phase consisting of n-hexane: 2-propanol:trifluoroacetic acid (95:5:0.2 v/v/v) at a flow rate of 1.0 mL min⁻¹. The resolution between the enantiomers was found to be not >3.5 in optimized method. The presence of trifluoroacetic acid in the mobile phase played an important role, in enhancing chromatographic efficiency and resolution between the enantiomers. The developed method was extensively validated and proved to be robust. The calibration curve for (R)-enantiomer showed excellent linearity over the concentration range of 900 ng mL⁻¹ (LOQ) to 6,000 ng mL⁻¹. The limit of detection and limit of quantification for (R)-enantiomer were 300 and 900 ng mL⁻¹, respectively. The percentage recovery of the (R)-enantiomer ranged between 98.3 and 101.05% in bulk drug samples of repaglinide. Repaglinide sample solution and mobile phase were found to be stable up to 48 h. The developed method was found to be enantioselective, accurate, precise and suitable for quantitative determination of (R)-enantiomer in bulk drug substance.     

Determination of olanzapine and desmethylolanzapine in the plasma of schizophrenic patients by means of an improved HPLC method with amperometric detection

Summary An improved HPLC method with electrochemical detection has been developed for the determination of olanzapine and its main metabolite, desmethylolanzapine, in human plasma. Chromatographic separation and analysis were performed on a C₈ reversed-phase column with a mixture of methanol, acetonitrile, and pH 3.7 phosphate buffer as mobile phase; 2-methylolanzapine was used as internal standard. Careful pretreatment of the plasma samples was implemented by means of solid phase extraction (SPE). Response was linearly dependent on concentration and precision was satisfactory over the concentration range 0.5–75.0 ng mL⁻¹ for both analytes. The limit of detection was 0.2 ng mL⁻¹ for both analytes. Application to plasma samples of patients treated with Zyprexa tablets gave good results. Because of its sensitivity and selectivity, and the need for small plasma samples, this method seems to be a useful tool for clinical monitoring.     

HPLC coupled with fluorimetric detection for the identification of natural resins in archaeological materials

Summary For better identification of chemical compounds in natural resins HPLC with UV-visible detection has been complemented with spectrofluorimetric detection. The fluorimetric response of many standards has been studied and typical patterns were obtained for several resins which are also found in ancient samples.     

Validation of an HPLC Analytical Method for Determination of Pancuronium Bromide in Pharmaceutical Injections

Abstract

Pancuronium bromide is used with general anesthesia in surgery for muscle relaxation and as an aid to intubation. A high performance liquid chromatographic method was fully validated for the quantitative determination of pancuronium bromide in pharmaceutical injectable solutions. The analytical method was performed on an amino column (Luna® 150 mm × 4.6 mm, 5 µm). The mobile phase was composed of acetonitrile:water containing 50 mmol L^?1 of 1-octane sulfonic acid sodium salt (20:80 v/v) with a flow rate of 1.0 mL min^?1 and ultraviolet (UV) detection at 210 nm. The proposed analytical method was compared with that described in the British Pharmacopoeia.     

Development and validation of an HPLC method for the simultaneous determination of clozapine and desmethylclozapine in plasma of schizophrenic patients

Summary A high-performance liquid chromatographic method with amperometric detection has been developed for the determination of levels of clozapine (CLZ) and its active metabolite N-desmethylclozapine (DMC) in human plasma. The analysis was performed on a 5 μm C8 reversed phase column (150×4.6 mm i.d.), with acetonitrile-phosphate buffer (pH 3.5), as the mobile phase. The detection voltage was +800 mV and the cell and column temperature were 50°C. Linear responses were obtained between 2 ng mL⁻¹ and 100 ng mL⁻¹. Absolute recovery for both clozapine and desmethylclozapine exceeded 88% and the detection limit was 1 ng mL⁻¹. Repeatability, intermediate precision and accuracy were satisfactory. The method, which is rapid, sensitive and selective, has been applied to therapeutic drug monitoring in schizophrenic patients following administration of Leponex^? tablets. In 21 patients in steady state at a mean daily clozapine dosage of 358 mg (ranging from 150 to 500 mg day⁻¹), clozapine levels averaged 379 ng mL⁻¹ (ranging from 102 to 818 ng mL⁻¹) and DMC levels averaged 233 ng mL⁻¹ (ranging from 70 to 540 ng mL⁻¹). The method requires only a very small amount of plasma (100 μL), and thus it is suitable for pharmacokinetic studies, as well as for therapeutic drug monitoring.     

A method for the determination of histamine in wine by HPLC with precolumn derivatization with phenylisothiocyanate

Summary A method for determining histamine in wine by precolumn derivatization with PITC (phenylisothiocyanate) with reversed-phase HPLC and UV detection is reported. Histamine can be determined together with the 24 amino acids within 40 min, or separately in a shorter time (less than 4 min) if a prior solid phase extraction clean-up is used.     

Development of an Ion-pair HPLC method for the determination of 2,4- and 2,6-toluendiamine in human plasma

Summary An ion-pair HPLC method is presented for the determination in plasma of 2,4- and 2,6-toluendiamine (TDA), known carcinogens. The chromatographic conditions consisted in isocratic elution on a reversed phase C₁₈ column with 5 mM octanesulfonic acid in methanol-water, 45∶55, as mobile phase. UV detection was performed at 235 nm. Samples were analyzed after a simple single step liquid-liquid extraction and the method was validated by measurement of precision (interassay and intraassay), sensitivity, specificity, linearity, and recovery. The detection limit for both TDAs in plasma was 20 ng mL⁻¹. The correlation coefficients based on the intrassay calibration curve were 0.998 and 0.997 for 2,6- and 2,4-TDA, respectively. The intraassay accuracy, expressed in terms of recovery, was found to be up to 89.91% and 97.05% for 2,6- and 2,4-TDA, respectively.     

Validation of a Novel HPLC Method for the Determination of Raloxifene and Its Pharmacokinetics in Rat Plasma

A novel HPLC method has been developed and validated for the determination of Raloxifene in rat plasma. Samples were prepared based on a simple protein precipitation. Separation of Raloxifene in plasma was performed on a C18 column, with a mobile phase of acetonitrile–ammonium acetate. Good linearity was demonstrated in the range of 0.2–75.0 μg mL⁻¹ (r = 0.9931). The method was used to measure the concentration and pharmacokinetics of Raloxifene in rat plasma after a single oral dose, and a linear pharmacokinetic profile of Raloxifene was found.     

Use of tryptophan peptides for an HPLC racemization test with fluorescence detection

A new HPLC test has been developed for monitoring the racemiza-tion which occurs during the coupling of Z-Ala-Trp-OH with Val-OMe by various methods. It is based on reversed phase HPLC separation of tripeptide diastereomers (LLL – LDL ) and fluorescence rather than UV detection. The extent of racemization has been estimated for different carbodiimides, mixed anhydrides, and additive-releasing reagents.